In this study, we approached the question whether breast cancer patients with an LFS/LFL-suggestive phenotype may harbor germline aberrations in known or proposed cancer susceptibility genes beyond TP53 and BRCA1/2. This evidence concerns the gene BRCA1 and breast carcinoma.